BridgeMD
New treatment option for Anxiety Disorders
Official title Brain STimulation for ANxiety and Depression in Youth
ClinicalTrials.gov ID: NCT06892847
What this study is testing
- What it's testing
- In this open-label trial, the overall aim is to determine if TMS treatment can improve anxiety and depression in a broad group of children and youth referred by physicians.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 18
You may be able to join if
- aged between 6 and 18 years old
- diagnosis of anxiety or depression made by a qualified medical professional
- active anxiety and/or depression symptoms
You likely can't join if
- status epilepticus in past 12-months
- presence of any disease, medical condition, or physical condition that, in the opinion of the study investigator may compromise, interfere, limit...
- hospitalization for suicide attempt within the past 3 months (unless participant is under the daily supervision of a physician, such as in a mental...
- TMS-related contraindications, including implanted medical devices (e.g., pacemaker)
- if actively taking prescription medication, no changes in medication for at least 3 months prior to entry into the study, with no anticipation of...
- unable to understand instructions in English
The study team makes the final eligibility decision.
Where it's taking place
- Calgary, Alberta, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Calgary, Alberta, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.